Eating disorders almost destroyed 28kg Hongkonger. How she beat them and now thrives
Advertisement
But life was not always so rosy for Millamena, who struggled with depression and eating disorders in her teenage years. She hit rock bottom in 2019 when, aged 18 and weighing just 28kg (62lb), she held a knife to her throat in the kitchen of her parents' home.
Her father intervened, and Millamena was hospitalised for a year after her suicide attempt.
Today, at a coffee shop in Central, Millamena can talk candidly about her battle with
anorexia nervosa – a condition that causes people to obsess about their weight and food – and
bulimia , which is characterised by binge eating followed by self-induced vomiting or fasting to prevent weight gain.
Millamena pictured in 2018. In her teenage years, she struggled with depression and eating disorders. Photo: courtesy of Miley Millamena
By sharing her story, Millamena hopes to destigmatise eating disorders and raise awareness about their grave impact.
Advertisement
She says they are not taken seriously in Hong Kong, and the fact that the city lacks official statistics on eating disorders strengthens her claim.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
4 hours ago
- South China Morning Post
Stay alert to chikungunya fever threat, leading expert tells Hongkongers
Hongkongers should stay vigilant against chikungunya fever, leading expert Yuen Kwok-yung has said, stressing that the mosquito-borne disease could cause prolonged and severe joint pain amid weak population immunity. Yuen, chair of infectious diseases at the University of Hong Kong's Department of Microbiology, made the warning on Thursday, following recent outbreaks in mainland China, including 3,000 cases reported in Foshan city in Guangdong province. While no chikungunya fever cases have been registered in Hong Kong since 2020, Yuen has said that any potential outbreak in the city could be on a large scale. 'Any outbreak could be major because we have no immunity, so we should not take it lightly,' he said during a radio show. 'Normally, you might only experience a fever, rash and swollen joints. Most people will be fine, but you must not forget that if you have a chronic illness, it can be very serious to those who are very old or very young. 'It can affect your brain and cause inflammation of the retina or even retinal detachment. It can also impact the heart.'
South China Morning Post
20 hours ago
- South China Morning Post
South Korea reverses birth rate decline with its fastest growth in 40 years
South Korea registered a record birth rate growth during the first five months of the year, a statistics agency official said on Wednesday. Advertisement The country has one of the world's longest life expectancies and lowest birth rates – a combination that presents a looming demographic challenge. Seoul has poured billions of dollars into efforts to encourage women to have more children and maintain population stability. 'The number of newborns for the January-May period stood at 106,048, a 6.9 per cent increase, the highest growth rate since such data collection began in 1981,' said Kang hyun-young from Statistics Korea. The surge follows South Korea's first annual increase in the number of births in more than a decade, driven by a rise in marriages. In 2024, the number of newborns rose by 8,300, or 3.6 per cent, to 238,300 from the previous year. Advertisement April in particular saw a spike, with year-on-year growth reaching 8.7 percent and the number of births totalling 20,717 that month.
South China Morning Post
a day ago
- South China Morning Post
China GLP-1 drug study suggests slim chance weight stays off after treatment
A Chinese analysis of prescription anti-obesity medications has added to evidence that people who use popular GLP-1 drugs such as Ozempic to shed pounds face the prospect of 'significant' weight rebound once they stop using them – challenges similar to those presented by more traditional slimming strategies. Patients saw 'significant weight' return eight weeks after anti-obesity medications (AOMs) were stopped, which continued after 20 weeks, the team from Peking University People's Hospital wrote in an article published in the peer-reviewed journal BMC Medicine on Tuesday. 'Weight regain is common in various weight-loss strategies and it is necessary to establish long-term anti-obesity treatment in clinical practice,' the researchers said. Worldwide, 2½ billion adults were overweight in 2022 and 890 million of them were obese, according to the World Health Organization 01:20 China approves popular weight-loss drug Wegovy produced by Danish firm Novo Nordisk China approves popular weight-loss drug Wegovy produced by Danish firm Novo Nordisk
